Quantitative Metrics of Net Proliferation and Invasion Link Biological Aggressiveness Assessed by MRI with Hypoxia Assessed by FMISO-PET in Newly Diagnosed Glioblastomas

被引:120
|
作者
Szeto, Mindy D.
Chakraborty, Gargi
Hadley, Jennifer
Rockne, Russ
Muzi, Mark [2 ]
Alvord, Ellsworth C., Jr.
Krohn, Kenneth A. [2 ]
Spence, Alexander M. [3 ]
Swanson, Kristin R. [1 ]
机构
[1] Univ Washington, Neuropathol Lab, Sch Med, Dept Pathol, Seattle, WA 98104 USA
[2] Univ Washington, Dept Radiol, Sch Med, Seattle, WA 98104 USA
[3] Univ Washington, Dept Neurol, Sch Med, Seattle, WA 98104 USA
关键词
POSITRON-EMISSION-TOMOGRAPHY; BRAIN-TUMORS; REGIONAL HYPOXIA; GROWTH-RATES; MODEL; FLUOROMISONIDAZOLE; RADIOTHERAPY; GLIOMAS; GRADE; F-18-FLUOROMISONIDAZOLE;
D O I
10.1158/0008-5472.CAN-08-3884
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Glioblastoma multiforme (GBM) are aggressive and uniformly fatal primary brain tumors characterized by their diffuse invasion of the normal-appearing parenchyma peripheral to the clinical imaging abnormality. Hypoxia, a hallmark of aggressive tumor behavior often noted in GBMs, has been associated with resistance to therapy, poorer survival, and more malignant tumor phenotypes. Based on the existence of a set of novel imaging techniques and modeling tools, our objective was to assess a hypothesized quantitative link between tumor growth kinetics [assessed via mathematical models and routine magnetic resonance imaging (MRI)] and the hypoxic burden of the tumor [assessed via positron emission tomography (PET) imaging]. Our biomathematical model for glioma kinetics describes the spatial and temporal evolution of a glioma in terms of concentration of malignant tumor cells. This model has already been proven useful as a novel tool to dynamically quantify the net rates of proliferation (rho) and invasion (D) of the glioma cells in individual patients. Estimates of these kinetic rates can be calculated from routinely available pretreatment MRI in vivo. Eleven adults with GBM were imaged preoperatively with F-18-fluoromisonidazole (FMISO)-PET and serial gadolinium-enhanced T1- and T2-weighted MRIs to allow the estimation of patient-specific net rates of proliferation (rho) and invasion (D). Hypoxic volumes were quantified from each FMISO-PET scan following standard techniques. To control for tumor size variability, two measures of hypoxic burden were considered: relative hypoxia (RH), defined as the ratio of the hypoxic volume to the T2-defined tumor volume, and the mean intensity on FMISO-PET scaled to the blood activity of the tracer (mean T/B). Pearson correlations between RH and the net rate of cell proliferation (rho) reached significance (P < 0.04). Moreover, highly significant positive correlations were found between biological aggressiveness ratio (rho/D) and both RH (P < 0.00003) and the mean T/B (P < 0.0007). [Cancer Res 2009;69(10):4502-9]
引用
收藏
页码:4502 / 4509
页数:8
相关论文
共 5 条
  • [1] Correlation of biological aggressiveness assessed by 11C-methionine PET and hypoxic burden assessed by 18F-fluoromisonidazole PET in newly diagnosed glioblastoma
    Kawai, Nobuyuki
    Maeda, Yukito
    Kudomi, Nobuyuki
    Miyake, Keisuke
    Okada, Masaki
    Yamamoto, Yuka
    Nishiyama, Yoshihiro
    Tamiya, Takashi
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (03) : 441 - 450
  • [2] Correlation of biological aggressiveness assessed by 11C-methionine PET and hypoxic burden assessed by 18F-fluoromisonidazole PET in newly diagnosed glioblastoma
    Nobuyuki Kawai
    Yukito Maeda
    Nobuyuki Kudomi
    Keisuke Miyake
    Masaki Okada
    Yuka Yamamoto
    Yoshihiro Nishiyama
    Takashi Tamiya
    European Journal of Nuclear Medicine and Molecular Imaging, 2011, 38 : 441 - 450
  • [3] Hypoxia and glucose metabolism assessed by FMISO and FDG PET for predicting IDH1 mutation and 1p/19q codeletion status in newly diagnosed malignant gliomas
    Kenta Suzuki
    Nobuyuki Kawai
    Tomoya Ogawa
    Keisuke Miyake
    Aya Shinomiya
    Yuka Yamamoto
    Yoshihiro Nishiyama
    Takashi Tamiya
    EJNMMI Research, 11
  • [4] Hypoxia and glucose metabolism assessed by FMISO and FDG PET for predicting IDH1 mutation and 1p/19q codeletion status in newly diagnosed malignant gliomas
    Suzuki, Kenta
    Kawai, Nobuyuki
    Ogawa, Tomoya
    Miyake, Keisuke
    Shinomiya, Aya
    Yamamoto, Yuka
    Nishiyama, Yoshihiro
    Tamiya, Takashi
    EJNMMI RESEARCH, 2021, 11 (01)
  • [5] Simultaneous Mapping of Vasculature, Hypoxia, and Proliferation Using Dynamic Susceptibility Contrast MRI, 18F-FMISO PET, and 18F-FLT PET in Relation to Contrast Enhancement in Newly Diagnosed Glioblastoma
    Collet, Solene
    Guillamo, Jean-Sebastien
    Berro, David Hassanein
    Chakhoyan, Ararat
    Constans, Jean-Marc
    Lechapt-Zalcman, Emmanuele
    Derlon, Jean-Michel
    Hatt, Mathieu
    Visvikis, Dimitris
    Guillouet, Stephane
    Perrio, Cecile
    Bernaudin, Myriam
    Valable, Samuel
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (10) : 1349 - 1356